Ovagen

Ovagen is an ultrashort peptide bioregulator studied for gastrointestinal and hepatic tissue signaling, with extremely limited evidence and dosing that involves very small subcutaneous volumes.

Profile · 01

Overview

Ovagen is a short tripeptide in the Khavinson bioregulator family and is discussed as a gastrointestinal and liver-related signaling peptide. The source frames it as an ultrashort peptide with theoretical low immunogenicity and rapid metabolism, but human clinical data are absent.

This is one of the most measurement-sensitive pages in the library because the source doses begin in the 10-20 mcg range. That means practical injection accuracy becomes just as important as the mechanistic discussion itself.

At a Glance

Goal
Support gastrointestinal and hepatic tissue bioregulation in an experimental research setting
Categories
GI HealthLiver SupportBioregulationAnti-Aging
Synergistic
BPC-157 · Livagen · NAC · Probiotics
Profile · 02

Protocol

Suggested once-daily microdose titration approach starting very low and increasing every one to two weeks.

Reconstitute
Add 2.0 mL bacteriostatic water to a 20 mg vial for 10 mg/mL concentration
Typical daily range
10-150 mcg once daily
Start
10 mcg daily for Weeks 1-2
Target
100-150 mcg daily by Weeks 7-16
Frequency
Once daily (subcutaneous)
Cycle Length
16 weeks
Timing
Any consistent time; rotate injection sites
Route
Subcutaneous
Cycle
16 weeks on, 4 weeks off

Inject once daily subcutaneously, but recognize that early doses are below 1 unit on a standard insulin syringe. The source explicitly flags this as a practical challenge and suggests smaller low-dead-space syringes for better readability. All dosing remains preclinical extrapolation.

Dose progression

Weeks 1-2
10 mcg · 0.1 units (0.001 mL)
Weeks 3-4
20 mcg · 0.2 units (0.002 mL)
Weeks 5-6
50 mcg · 0.5 units (0.005 mL)
Weeks 7-8
100 mcg · 1 unit (0.01 mL)
Weeks 9-16
100-150 mcg · 1-1.5 units (0.01-0.015 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How Ovagen works.

Ovagen is presented as an ultrashort peptide bioregulator that may influence gene expression and protein synthesis relevant to GI and hepatic tissue maintenance. The source points to cell-penetration and epigenetic-regulation discussions from the Khavinson peptide literature.

The actual evidence base remains highly limited. Human pharmacokinetics, bioavailability, efficacy, and safety for subcutaneous use are essentially uncharacterized, so this entry should be treated as exploratory even by peptide-library standards.

Science · 02

Effects

Observations from clinical or preclinical literature.

May support gastrointestinal and hepatic tissue-regulation research through bioregulatory signaling hypotheses
Ultrashort peptides are often discussed as low-immunogenicity compounds
The source cites in vitro support for cell-protective and aging-marker effects
Human efficacy and tolerability data are absent
Mild injection-site irritation may occur
Measurement error is a major practical risk because doses are so small
Science · 03

Caution

Not recommended during pregnancy or breastfeeding because safety data is absent
Use caution in active cancer or proliferative disorders because cell-signaling effects are not fully characterized
Use caution in chronic gastrointestinal or hepatic disease without qualified oversight
No human pharmacokinetic data exist, so protocol precision and humility matter here

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Zinc
Supports GI mucosal integrity and enzyme function.
Vitamin A
Relevant to epithelial maintenance and tissue health.
NAC
Supports hepatic glutathione production and detoxification pathways.
Probiotics
May complement GI-health goals through microbiome support.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Use a whole-food diet that supports gut and liver health
Avoid excessive alcohol and other hepatotoxic stressors during the protocol
Prioritize sleep and stress management because GI and liver resilience are strongly stress-linked
Keep expectations conservative because evidence is limited and dose measurement is difficult
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Digestive comfort and bowel regularity - helpful for GI-response tracking
  2. Appetite and food tolerance - may reflect gastrointestinal changes
  3. Subjective energy and overall well-being - useful broad context marker
  4. Injection-site reactions - note redness, swelling, or discomfort
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

CMP (Comprehensive Metabolic Panel)
Assesses liver enzymes and kidney function.
CBC (Complete Blood Count)
General baseline and follow-up safety context.
GGT
Useful additional liver marker.
CRP (C-Reactive Protein)
Provides broader inflammatory context.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 20 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Use low-dead-space syringes where possible because the early protocol uses extremely small volumes
Rotate sites across the abdomen, thighs, and upper arms and discard syringes safely

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use a new sterile syringe for each injection and dispose of it safely
This protocol includes doses below 1 unit on a U-100 syringe, so practical measurement limits are a real concern
Document the exact dilution and dose strategy carefully for consistency
This is a highly experimental entry with no human clinical trial base
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.
Reference · 02

References

  1. MDPI Molecules
    Khavinson short-peptide work on modulation of endonuclease effects.
    https://www.mdpi.com/1420-3049/25/22/5306
  2. PubMed
    Review describing peptide bioregulators as a new class of geroprotectors.
    https://pubmed.ncbi.nlm.nih.gov/25482216/
  3. Scientific Reports
    Mechanisms of biological activity of short peptides and epigenetic regulation.
    https://www.nature.com/articles/s41598-020-67769-3
  4. WHO / NCBI Bookshelf
    Guidance on syringe and injection safety practices.
    https://www.ncbi.nlm.nih.gov/books/NBK390474/
  5. CDC
    Subcutaneous injection route guidance.
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
On this page